ALB · Intrinsic value
Is Albemarle Corporation (ALB) overvalued or undervalued?
Albemarle Corporation (ALB) trades at the delayed market price of $95.98 a share. That price already implies revenue growth of more than 25%/yr. TickerWorth's fair value is $188.68 a share (priced within our range of $83.17 – $233.89). We do not call it over- or undervalued from inside our range. It is a model estimate; every input is sourced below.
Model by Miraaj Patel · generated from market data · Updated Oct 19, 2026 · How these pages are made
Is ALB fairly valued?
- Fair value
- $188.68
- Market price
- $95.98
- Upside to fair value
- +96.6%
- Verdict
- Priced within our range of $83.17 – $233.89
Reverse DCF, on our cash-flow model rather than the fair value above: Today's price implies revenue growth of more than 25%/yr. Above about 25% a year the reverse-DCF stops being informative. It solves for revenue growth alone — holding margins, capital intensity and the forecast horizon fixed — so a price well above our cash-flow model's value has nowhere to go but growth, and the solver returns a rate the model can't reconcile. Read it as "the price implies growth we can't justify", not as a forecast.
What is ALB's TickerWorth Score?
Scores higher than most companies we compare it with
Compared with Basic Materials companies in US
Its strongest point: trades below our estimate of what it's worth. Its weakest: recent price trend has been weak.
our cash-flow model doesn't fit this business, so we won't award our top grade off the remaining lenses
- Value · 57 of 100
Cheaper than 57% of Basic Materials companies in US
- Price vs worth · 100 of 100
- Quality · 39 of 100
More profitable than 39% of Basic Materials companies in US
- Financial health · 71 of 100
Financially stronger than 71% of Basic Materials companies in US
- Growth · 90 of 100
Growing faster than 90% of Basic Materials companies in US
- Momentum · 14 of 100
Outperformed 14% of Basic Materials companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
ALB DCF valuation, input by input
TickerWorth's fair value for Albemarle Corporation (ALB) is $188.68 a share, against the delayed market price of $95.98 (priced within our range of $83.17 – $233.89). We do not call it over- or undervalued from inside our range. It is a model estimate, and every input behind it is sourced below.
Read the full reasoning
For this company that blend leans on peer multiples: our discounted-cash-flow model understates a business growing this fast, so read the gap as how the market prices it against comparable companies, not as a finding on cash flow. This is an educational model, not a price target or a recommendation.
The valuation discounts Albemarle Corporation's projected free cash flows at a weighted-average cost of capital (WACC) of 10.7%, with a long-run terminal growth rate of 2.5%. About 110% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is unusually high — most of the answer comes from a single assumption about the far future, so treat this figure as low-confidence and lean on the multiples alongside it.
Running the DCF in reverse — solving for the growth the current price already assumes — ALB would need sustained revenue growth of more than 25%/yr to justify today's price, against about 11.2% a year compounded in our base case. We don't quote a precise figure here, because past about 25% a year the reverse-DCF stops being informative: it solves for revenue growth alone, holding margins, capital intensity and the forecast horizon fixed, so a price well above our fair value has nowhere to go but growth. The honest reading is that the price implies growth this model can't reconcile — not that we forecast it.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, ALB's modeled DCF value ranges from about $12.72 to $34.46 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what Albemarle Corporation would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of ALB's intrinsic value. Figures update as new filings and prices come in.
Every input behind ALB's DCF
| Input | Value |
|---|---|
| Base-year revenueLive feed — totalRevenue (TTM) | $5,907,900,000 |
| Base EBIT marginComputed — reported operating margin exceeded the EBITDA margin (impossible); held to 23.1% so D&A stays positive | 23.1% |
| Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast | 19% → 15% → 11% → 8% → 4% |
| Risk-free rateLive feed — US 10-year Treasury yield (^TNX) | 5.3% |
| BetaLive feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) | 1.33 |
| Terminal growthESTIMATEAssumption — TickerWorth house default 2.5%, held below WACC | 2.5% |
| Diluted sharesLive feed — sharesOutstanding | 118M |
| Market priceLast known price · as of 2026-10-19 20:15 UTC | $95.97 |
Change ALB's assumptions
The discount-rate dial and the editable model
ProChange growth, margin and WACC yourself — Pro (7-day free trial, card required).
What does Albemarle Corporation do?
What does it do?
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. It operates in the Specialty Chemicals industry (Basic Materials sector), headquartered in United States. The company employs roughly 7,800 people.
How does it make money?
The business turns $5.1B in annual revenue into profit. Out of every $100 of sales, about $28 is left as operating profit (operating margin of 27.7%), after a 24% gross margin on the products/services it sells. After all costs, taxes and interest, 3.8% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks solid: carries modest debt (0.2× equity), comfortably covers its short-term bills (2.1× current ratio), and is currently profitable.
Who at ALB filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| Wolff Alejandro Daniel | Director | Grant / award | — | Form 4 for Wolff Alejandro Daniel (opens sec.gov in a new tab) | |
| Norris Eric | Chief Commercial Officer | Grant / award | — | Form 4 for Norris Eric (opens sec.gov in a new tab) | |
| Mummert Mark Richard | Chief Operations Officer | Grant / award | — | Form 4 for Mummert Mark Richard (opens sec.gov in a new tab) | |
| Gagarinas Autumn M. | Chief People Officer | Grant / award | — | Form 4 for Gagarinas Autumn M. (opens sec.gov in a new tab) | |
| Hood Max | Chief Accounting Officer | Grant / award | — | Form 4 for Hood Max (opens sec.gov in a new tab) | |
| DESALLES BARTOLOMEO EDUARDO | Director | Grant / award | — | Form 4 for DESALLES BARTOLOMEO EDUARDO (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Common questions
What is ALB's intrinsic value?
TickerWorth's blended fair value for Albemarle Corporation (ALB) is $188.68 per share, versus a market price of $95.98 (priced within our range of $83.17 – $233.89).
Is ALB overvalued or undervalued?
Priced within our range of $83.17 – $233.89 at $95.98. We don't call ALB overvalued or undervalued from a range. This is an educational estimate, not advice.
What discount rate is used for ALB?
A WACC of 10.7% and a terminal growth rate of 2.5%.
Is Albemarle stock undervalued?
TickerWorth's fair value for Albemarle Corporation (ALB) is $188.68 against a market price of $95.98. Our read: Priced within our range of $83.17 – $233.89. This is a model estimate, not investment advice.
Albemarle (ALB) DCF valuation and fair value
Our fair value for Albemarle Corporation (ALB) is $188.68, built on a 10.7% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.
What growth is priced into Albemarle stock?
Today's price implies revenue growth of more than 25%/yr. Above about 25% a year the reverse-DCF stops being informative. It solves for revenue growth alone — holding margins, capital intensity and the forecast horizon fixed — so a price well above our cash-flow model's value has nowhere to go but growth, and the solver returns a rate the model can't reconcile. Read it as "the price implies growth we can't justify", not as a forecast. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of $95.98. A model estimate, not investment advice.
Albemarle (ALB) insider trading
The most recent insider filing (SEC Form 4) for Albemarle Corporation (ALB): Wolff Alejandro Daniel, Director, grant / award on 2026-10-01. The latest filings are listed on this page. A disclosure, not a signal to trade.
Not investment advice. TickerWorth Score is a model output.
Educational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public filings and market data that can be wrong.